Stock listing
Gt Biopharma, Inc.
Selected listing: GTBP · BOATS · USD · US
Gt Biopharma, Inc. (BOATS:GTBP), Health Technology. Latest release Sep 15, 2026: GT Biopharma Announces Potential New Indication for GTB-5550…
- Ticker
- BOATS:GTBP
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- BOATS
- Currency
- USD
About Gt Biopharma, Inc.
Gt Biopharma, Inc. is a public company traded under the ticker GTBP in the American market. Gt Biopharma focuses on developing innovative therapies in the biopharmaceutical sector.
Latest news from Gt Biopharma, Inc.
GT Biopharma Announces Potential New Indication for GTB-5550, a B7-H3-Targeted Natural Killer (NK) Cell Engager, for Multiple Myeloma
September 15, 2026
GT Biopharma to Host Live Company Presentation on the Development of TriKE® Platform for Cancer Treatment, September 11, 2026
September 11, 2026
GT Biopharma Reports Second Quarter 2026 Financial Results
August 14, 2026
Three Cancer Drugs Have Reached the Clinic: Inside GT Biopharma's TriKE Bet
June 7, 2026
GT Biopharma Provides Update on Pipeline Discovery Activities from Newly Implemented AI-Based Technological Initiatives
June 1, 2026
Events
Replays
GT Biopharma, Inc. (GTBP) Q2 2021 Earnings Call
Fri, Aug 13, 2021 · 08:30 AM ET
Watch
Research Gt Biopharma, Inc.
Alternate listings
GTBP:NASDAQ
US · USD
Alternate listing for Gt Biopharma, Inc.; the primary context on this page is GTBP:BOATS.
OXIA:GETTEX
DE · EUR
Alternate listing for Gt Biopharma, Inc.; the primary context on this page is GTBP:BOATS.
OXIA:MUN
DE · EUR
Alternate listing for Gt Biopharma, Inc.; the primary context on this page is GTBP:BOATS.
OXIA:SWB
DE · EUR
Alternate listing for Gt Biopharma, Inc.; the primary context on this page is GTBP:BOATS.
OXIA:FWB
DE · EUR
Alternate listing for Gt Biopharma, Inc.; the primary context on this page is GTBP:BOATS.